Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer

Y. Maehara, K. Sugimachi, M. Akagi, T. Kakegawa, H. Shimazu, M. Tomita

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

We studied the effect of early postoperative chemotherapy, including 5-fluorouracil (5-FU) for 5 days for patients with gastric cancer following noncurative resection. The study was prospectively randomised and controlled, and 162 (87. 1%) of 186 were eligible candidates for statistical assessment. Patients randomised to group A received therapy that is used widely to treat patients with gastric cancer in Japan; mitomycin C (MMC). OK-432. UFT and PSK. Patients randomised to group B received the same drugs given to group A plus 5-FU bolus injections for 5 days, beginning on postoperative day 2. There were no differences in prognostic factors and doses of the drugs prescribed, except for 5-FU. There was no difference in the toxicity rate between the groups. Generalised Wilcoxon test revealed a P value of 0. 169. and the 50% survival rate improved 1. 4-fold in patients with gastric cancer treated with early postoperative chemotherapy of MMC. OK-432 plus 5-FU injection.

Original languageEnglish
Pages (from-to)413-416
Number of pages4
JournalBritish journal of cancer
Volume65
Issue number3
DOIs
Publication statusPublished - Mar 1992

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer'. Together they form a unique fingerprint.

Cite this